![Shirish Hirani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Shirish Hirani
Former positions of Shirish Hirani
Companies | Position | Start | End |
---|---|---|---|
ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2005-09-30 | 2017-03-31 |
Transkaryotic Therapies, Inc.
![]() Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Corporate Officer/Principal | 2001-12-31 | 2004-12-31 |
DYAX CORP. | Corporate Officer/Principal | 1996-12-31 | 2001-12-31 |
ARQULE, INC. | Corporate Officer/Principal | - | - |
Training of Shirish Hirani
Queen Elizabeth College | Doctorate Degree |
Statistics
International
United States | 5 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Transkaryotic Therapies, Inc.
![]() Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Dyax Corp.
![]() Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
![]() ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
ArQule, Inc.
![]() ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
- Stock Market
- Insiders
- Shirish Hirani
- Experience